E942.7 - Antivaricose Drugs, Including Sclerosing Agents, Causing Adverse Effects In Therapeutic Use

The ICD 9 Code for Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use is listed as E942.7.
Additional information concerning this code and description can be found below including ICD 10 crosswalks / GEMS, and chapter information where available.

ICD 9 CM Field	Value
Diagnosis Code:	E942.7
Long Description:	Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use
Short Description:	Adv eff antivaricose

Chapter:	Supplementary Classification Of External Causes Of Injury And Poisoning
Block:	Drugs, Medicinal And Biological Substances Causing Adverse Effects In Therapeutic Use (E930-E949)
ICD-9-CM Siblings (same level / similar specificity) of E942.7:
E942.0 - Cardiac rhythm regulators causing adverse effects in therapeutic use
E942.1 - Cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use
E942.2 - Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use
E942.3 - Ganglion-blocking agents causing adverse effects in therapeutic use
E942.4 - Coronary vasodilators causing adverse effects in therapeutic use
E942.5 - Other vasodilators causing adverse effects in therapeutic use
E942.6 - Other antihypertensive agents causing adverse effects in therapeutic use
E942.8 - Capillary-active drugs causing adverse effects in therapeutic use
E942.9 - Other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use